Svetlana Lucas insider trades

Open-market stock purchases and sales by Svetlana Lucas, Chief Business Officer at Scribe Therapeutics, Inc, from SEC Form 4 filings since Jun 28, 2019.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -24%.

Recent trades

DateStockTradeValue
Jul 23, 2026SCTX Scribe Therapeutics, IncBought$45K
Jul 23, 2026SCTX Scribe Therapeutics, IncBought (not open market)—
May 11, 2026ATYR aTYR PHARMA IncBought (not open market)—
Mar 13, 2026SCTX Scribe Therapeutics, IncBought (not open market)—

Companies traded

  • SCTX Scribe Therapeutics, Inc: 1 buy, last Jul 23, 2026
  • ATYR aTYR PHARMA Inc: other filings, last May 11, 2026
  • JSPR Jasper Therapeutics, Inc: 1 buy, last Sep 22, 2025
  • LIFE aTYR PHARMA Inc: other filings, last May 22, 2024

Get free alerts when Svetlana Lucas files a new trade →